Annora Pharma Partners with AI-Native Traceability Platform AltiusHub to Strengthen Global Drug Traceability

▴ (Left to Right) Mr. Siddharth Reddy, Managing Director of AltiusHub, and Mr. Bhaskar Reddy, Director at Hetero Group, following the announcement of the strategic partnership between AltiusHub and Annora Pharma.
Annora Pharma, the formulations subsidiary of Hetero Group and a leading Indian pharmaceutical manufacturer, has expanded its collaboration with AltiusHub.

National, India, May 28, 2026: Annora Pharma, the formulations subsidiary of Hetero Group and a leading Indian pharmaceutical manufacturer, has expanded its collaboration with AltiusHub. The company is deploying AltiusHub’s AI-native serialization, track & trace, and regulatory compliance platform across its export operations.

The deployment is designed to improve serialization efficiency by up to 45%. It will also strengthen operational visibility across Annora Pharma’s global supply chain. The rollout supports compliance across key export markets, including the US, EU, GCC, LATAM, and ASEAN regions.

Annora Pharma aims to achieve real-time visibility across 100% of serialized drug products within three months. This visibility will span the full journey from packaging line to export dispatch.

The unified platform replaces fragmented legacy systems. It supports serialization, aggregation, and multi-market regulatory reporting. It also integrates with Annora Pharma’s Level 3 packaging infrastructure.

AltiusHub’s AI-driven analytics and automated exception management help improve operational efficiency. They also accelerate issue resolution and strengthen compliance oversight across markets.

The rollout reflects a broader shift in the pharmaceutical industry. Manufacturers are moving away from fragmented and vendor-dependent serialization systems. They are now adopting unified platforms that offer better control, faster implementation, and stronger supply chain visibility.

The deployment has already resulted in faster serialization processing and improved packaging floor productivity. It has also enhanced real-time visibility across export supply chains. These capabilities are becoming critical as pharmaceutical manufacturers respond to evolving regulatory mandates and increasing supply chain complexity.

“As supply chains become more complex, limited data access in legacy systems is becoming a growing challenge. While technology has advanced, many systems have not kept pace. Today, pharmaceutical companies need solutions that provide greater control over their data and processes. AltiusHub has enabled our teams to manage serialization and traceability workflows with greater transparency, flexibility, and independence.” - Dr Bhaskar Reddy, Director, Hetero Group

“We need systems that give our teams real-time visibility, faster issue resolution, and greater control over compliance workflows. AltiusHub has helped us simplify these operations while improving efficiency across the packaging and dispatch process.” - Mr Sridhar Reddy, Operations Head, Annora Pharma 

“For a long time, pharma companies have had to accept that traceability implementations are slow, resource-intensive, and heavily dependent on vendors. AltiusHub’s go-live at Annora Pharma shows that this model is changing. An AI-native solution like AltiusHub delivers speed, scalability, and control while meeting the strict regulatory standards the industry requires.” - Siddharth Reddy, Managing Director, AltiusHub

Within two years of inception, AltiusHub has enabled serialization and compliance operations across more than 50 regulated markets. These include the United States under DSCSA, the European Union under FMD, Saudi Arabia under SFDA, the UAE under Tatmeen, Russia under Chestny ZNAK, and other export destinations.

AltiusHub has also supported pharmaceutical traceability requirements for public health supply programs serving African markets under global healthcare initiatives.

Tags : #

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026